Founding Senior AI Engineer – Drug Discovery & Healthcare AI ( Equity)
Top Benefits
About the role
Bactrix is looking for a Founding Senior AI Engineer to help shape the core technology behind an AI-driven drug repurposing platform for antimicrobial resistance (AMR) — one of the most urgent, underfunded problems in global health.
This is a hands-on, high-ownership role for someone who genuinely loves building — not maintaining, but inventing. You'll work directly with our founder and science team to push the platform's discovery engine, agent architecture, and reasoning pipeline forward, finding smart, low-cost ways to make the system more capable without needing big infrastructure or big budgets.
What You'll Do
- Architect and improve our multi-agent AI pipeline (LLMs, RAG, agent orchestration) for pharmaceutical/biomedical discovery.
- Find creative, resource-efficient ways to increase model capability and accuracy without expensive infrastructure.
- Collaborate directly with our science team to ensure AI outputs are scientifically grounded and trustworthy.
- Help define technical direction and architecture as a founding-level technical voice, not just an execution hire.
What We're Looking For
- Genuine expertise in AI/ML, LLMs, and agentic systems — someone who can innovate, not just implement.
- Experience in or strong familiarity with pharma, biotech, or life sciences applications of AI.
- Comfortable operating lean — building smart, cost-efficient solutions at an early-stage startup, not enterprise-scale budgets.
- A founder mindset: ownership, initiative, and genuine belief in the mission.
Terms
- Remote
- Equity-based compensation at this stage (pre-seed); cash compensation and equity terms to be discussed as funding is secured
- Flexible but meaningful weekly commitment
About Bactrix
Bactrix is building the AI discovery layer for antimicrobial resistance.
We turn resistant pathogen profiles into ranked, wet-lab-ready drug repurposing dossiers — helping labs, biotech teams, and pharma partners decide which AMR rescue hypotheses deserve validation first.
Not another prediction tool.
A faster path from resistance data to experimental action.
Similar Jobs
Founding Senior AI Engineer – Drug Discovery & Healthcare AI ( Equity)
Top Benefits
About the role
Bactrix is looking for a Founding Senior AI Engineer to help shape the core technology behind an AI-driven drug repurposing platform for antimicrobial resistance (AMR) — one of the most urgent, underfunded problems in global health.
This is a hands-on, high-ownership role for someone who genuinely loves building — not maintaining, but inventing. You'll work directly with our founder and science team to push the platform's discovery engine, agent architecture, and reasoning pipeline forward, finding smart, low-cost ways to make the system more capable without needing big infrastructure or big budgets.
What You'll Do
- Architect and improve our multi-agent AI pipeline (LLMs, RAG, agent orchestration) for pharmaceutical/biomedical discovery.
- Find creative, resource-efficient ways to increase model capability and accuracy without expensive infrastructure.
- Collaborate directly with our science team to ensure AI outputs are scientifically grounded and trustworthy.
- Help define technical direction and architecture as a founding-level technical voice, not just an execution hire.
What We're Looking For
- Genuine expertise in AI/ML, LLMs, and agentic systems — someone who can innovate, not just implement.
- Experience in or strong familiarity with pharma, biotech, or life sciences applications of AI.
- Comfortable operating lean — building smart, cost-efficient solutions at an early-stage startup, not enterprise-scale budgets.
- A founder mindset: ownership, initiative, and genuine belief in the mission.
Terms
- Remote
- Equity-based compensation at this stage (pre-seed); cash compensation and equity terms to be discussed as funding is secured
- Flexible but meaningful weekly commitment
About Bactrix
Bactrix is building the AI discovery layer for antimicrobial resistance.
We turn resistant pathogen profiles into ranked, wet-lab-ready drug repurposing dossiers — helping labs, biotech teams, and pharma partners decide which AMR rescue hypotheses deserve validation first.
Not another prediction tool.
A faster path from resistance data to experimental action.